Huapont Life Sciences Co Ltd Asset Resilience Ratio
Huapont Life Sciences Co Ltd asset resilience ratio. Huapont Life Sciences Co Ltd (002004) has an Asset Resilience Ratio of 4.09% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Huapont Life Sciences Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Huapont Life Sciences Co Ltd (2004–2025)
Asset resilience ratio of Huapont Life Sciences Co Ltd from 2004 to 2025. This chart shows how Huapont Life Sciences Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Huapont Life Sciences Co Ltd carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Huapont Life Sciences Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 002004 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.20 Billion | 4.09% |
| Total Liquid Assets | CN¥1.20 Billion | 4.09% |
Asset Resilience Insights
- Limited Liquidity: Huapont Life Sciences Co Ltd maintains only 4.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Huapont Life Sciences Co Ltd Industry Peers by Asset Resilience Ratio
Compare Huapont Life Sciences Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
CF Industries Holdings Inc
NYSE:CF |
Agricultural Inputs | 9.60% |
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486 |
Agricultural Inputs | 1.86% |
|
Chengdu Wintrue Holding Co Ltd
SHE:002539 |
Agricultural Inputs | 0.02% |
|
Limin Chemical Co Ltd
SHE:002734 |
Agricultural Inputs | 1.86% |
|
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556 |
Agricultural Inputs | 0.04% |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731 |
Agricultural Inputs | 29.03% |
|
National Fertilizers Limited
NSE:NFL |
Agricultural Inputs | 0.90% |
|
Insumos Agroquimicos SA
BA:INAG |
Agricultural Inputs | 1.46% |
Huapont Life Sciences Co Ltd Asset Resilience Ratio by Year (2004–2025)
Huapont Life Sciences Co Ltd asset resilience ratio by year from 2004 to 2025. The table below shows the annual Asset Resilience Ratio data for Huapont Life Sciences Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.42% | CN¥993.30 Million ≈ $145.35 Million |
CN¥29.03 Billion ≈ $4.25 Billion |
+1.20pp |
| 2024-12-31 | 2.22% | CN¥653.87 Million ≈ $95.68 Million |
CN¥29.45 Billion ≈ $4.31 Billion |
+0.17pp |
| 2023-12-31 | 2.05% | CN¥630.28 Million ≈ $92.23 Million |
CN¥30.73 Billion ≈ $4.50 Billion |
-0.30pp |
| 2022-12-31 | 2.35% | CN¥706.29 Million ≈ $103.35 Million |
CN¥30.02 Billion ≈ $4.39 Billion |
-1.08pp |
| 2021-12-31 | 3.43% | CN¥1.03 Billion ≈ $150.78 Million |
CN¥30.04 Billion ≈ $4.40 Billion |
+0.37pp |
| 2020-12-31 | 3.05% | CN¥862.27 Million ≈ $126.18 Million |
CN¥28.23 Billion ≈ $4.13 Billion |
+0.48pp |
| 2019-12-31 | 2.57% | CN¥684.89 Million ≈ $100.22 Million |
CN¥26.64 Billion ≈ $3.90 Billion |
-2.00pp |
| 2018-12-31 | 4.57% | CN¥1.21 Billion ≈ $177.50 Million |
CN¥26.55 Billion ≈ $3.89 Billion |
+4.57pp |
| 2017-12-31 | 0.00% | CN¥196.48K ≈ $28.75K |
CN¥29.09 Billion ≈ $4.26 Billion |
-6.45pp |
| 2016-12-31 | 6.45% | CN¥1.56 Billion ≈ $228.72 Million |
CN¥24.23 Billion ≈ $3.55 Billion |
+5.91pp |
| 2015-12-31 | 0.54% | CN¥107.39 Million ≈ $15.72 Million |
CN¥19.71 Billion ≈ $2.88 Billion |
+0.52pp |
| 2014-12-31 | 0.02% | CN¥2.76 Million ≈ $404.35K |
CN¥13.57 Billion ≈ $1.99 Billion |
-1.02pp |
| 2013-12-31 | 1.04% | CN¥79.20 Million ≈ $11.59 Million |
CN¥7.65 Billion ≈ $1.12 Billion |
-0.45pp |
| 2012-12-31 | 1.48% | CN¥87.90 Million ≈ $12.86 Million |
CN¥5.92 Billion ≈ $866.61 Million |
+1.47pp |
| 2010-12-31 | 0.02% | CN¥242.36K ≈ $35.46K |
CN¥1.36 Billion ≈ $198.77 Million |
-0.98pp |
| 2006-12-31 | 1.00% | CN¥7.62 Million ≈ $1.12 Million |
CN¥765.08 Million ≈ $111.96 Million |
-0.53pp |
| 2005-12-31 | 1.52% | CN¥7.28 Million ≈ $1.07 Million |
CN¥477.85 Million ≈ $69.92 Million |
+0.78pp |
| 2004-12-31 | 0.74% | CN¥3.58 Million ≈ $524.15K |
CN¥481.04 Million ≈ $70.39 Million |
-- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. It is involved in the production and sale of pharmaceutical preparations and raw materials. The company also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more